Clinical Trials Browser

Completed × Nadroparin × Clear all

Neoplasms, Pulmonary Embolism

NCT00312013 2017-03-23

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Phase 3 Completed

503 enrolled

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Prostatic Neoplasms, Venous Thrombosis

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase 2/3 Completed

100 enrolled

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Phase NA Completed

362 enrolled

Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Phase 3 Completed

1,166 enrolled

Neoplasm Metastasis, Neoplasms, Thromboembolism

Clinical Trials

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)